Biotechnology - Biotechnology, USA

Filter

Current filters:

BiotechnologyUSA

Popular Filters

1 to 25 of 285 results

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

US FDA approves NPS Pharma’s Natpara

US FDA approves NPS Pharma’s Natpara

24-01-2015

The US Food and Drug Administration on Friday approved NPS Pharmaceuticals’ Natpara (parathyroid hormone)…

BiotechnologyNatparaNPS PharmaceuticalsRare diseasesRegulationShireUSA

BIO responds to President Obama's State of the Union speech

22-01-2015

In his State of the Union speech to the American public this week, US President Barak Obama said that…

BiotechnologyPoliticsResearchUSA

Latest approval for Novartis’ Cosentyx, from US FDA

Latest approval for Novartis’ Cosentyx, from US FDA

22-01-2015

Adding to recent marketing clearances in Japan and the European Union, the US Food and Drug Administration…

BiotechnologyCosentyxDermatologicalsNovartisRegulationUSA

FDA removes hold on CytRx's aldoxorubicin Phase III trials

FDA removes hold on CytRx's aldoxorubicin Phase III trials

20-01-2015

The US Food and Drug Administration has removed the partial clinical hold on biopharma oncology company…

aldoxorubicinBiotechnologyCytRxOncologyRegulationResearchUSA

Motif Biosciences agrees to merge with company holding IP to potential MRSA antibiotic

Motif Biosciences agrees to merge with company holding IP to potential MRSA antibiotic

19-01-2015

Motif Biosciences, a partner of life science business developer Amphion Innovations, has entered into…

Amphion InnovationsAntibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsMotif BiosciencesMRSA antibioticUSA

Seth Elliott appointed president and chief operating officer of Immune Therapeutics

14-01-2015

Immunotherapy specialist Immune Therapeutics has appointed Seth Elliott as president and chief operating…

BiotechnologyBoardroomImmune TherapeuticsImmunologicalsUSA

Celgene exercises option on Agios Pharma’ AG-120

Celgene exercises option on Agios Pharma’ AG-120

14-01-2015

US cancer metabolism specialist Agios Pharmaceuticals says that biotech major Celgene will exercise its…

AG-120Agios PharmaceuticalsBiotechnologyCelgene CorpLicensingOncologyUSA

Aegerion Pharma under SEC investigation

Aegerion Pharma under SEC investigation

14-01-2015

US biotech firm Aegerion Pharmaceuticals has revealed it is the subject of a US Securities and Exchange…

Aegerion PharmaceuticalsBiotechnologyBrazilCardio-vascularJuxtapidLegalMarkets & MarketingRare diseasesUSA

Tekmira to merge with OnCore, to create major hep B company

Tekmira to merge with OnCore, to create major hep B company

14-01-2015

Shares of Tekmira Pharmaceuticals leapt as much as 50% after it announced a merger with privately-held…

Anti-viralsBiotechnologyOnCore BioPharmaOnCore BioPharmaTekmira PharmaceuticalsUSA

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Amgen to collaborate with University of Texas on BiTE technology

Amgen to collaborate with University of Texas on BiTE technology

13-01-2015

US biotech major Amgen is to collaborate with the MD Anderson Cancer Center at the University of Texas…

AmgenBiotechnologyOncologyResearchUSA

Harvoni scores another victory with inclusion on Prime’s preferred list

Harvoni scores another victory with inclusion on Prime’s preferred list

13-01-2015

US pharmacy Prime Therapeutics has agreed to provide hepatitis C drug Harvoni (ledipasvir/sofosbuvir)…

Antibiotics and Infectious diseasesBiotechnologyGileadHarvoniPricingUSA

Hospira submits new BLA for epoetin alfa biosimilar In USA

12-01-2015

US injectable drugs and infusion technologies and biosimilars developer Hospira has submitted a Biologics…

AmgenBiosimilarsBiotechnologyepoetinEpogenHematologyHospiraJanssenJohnson & JohnsonProcritRegulationRetacritUSA

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

09-01-2015

US biotech firm Biogen Idec has announced positive top-line results from its Phase II trial of anti-LINGO-1…

anti-LINGO-1Biogen IdecBiotechnologyOphthalmicsResearchUSA

BIO urges US FDA to release guidance on biosimilars

BIO urges US FDA to release guidance on biosimilars

08-01-2015

The US trade group the Biotechnology Industry Organization (BIO) has called on the Food and Drug Administration…

BiosimilarsBiotechnologyRegulationUSA

Sandoz’ Neupogen biosimilar backed by FDA advisory panel

Sandoz’ Neupogen biosimilar backed by FDA advisory panel

08-01-2015

The US Food and Drug Administration Oncologic Drugs Advisory Committee (ODAC), in a unanimous vote, recommended…

AmgenBiosimilarsBiotechnologyFilgrastimNeupogenNovartisOncologyRegulationSandozUSAZarxio

Isis Pharmaceuticals appoints Sarah Boye as chief business officer

Isis Pharmaceuticals appoints Sarah Boye as chief business officer

07-01-2015

Isis Pharma, the biopharma Crohn’s disease specialist, has appointed Sarah Boyce to the newly-created…

BiotechnologyBoardroomIsis PharmaIsis PharmaceuticalsUSA

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

06-01-2015

In briefing papers ahead of an advisory committee meeting, agency staff at the US Food and Drug Administration…

AmgenBiosimilarsBiotechnologyImmunologicalsNeupogenNovartisRegulationUSA

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

05-01-2015

Oncology biotech company CytomX has appointed Michael Kavanaugh as chief scientific officer and head…

BiotechnologyBoardroomCytomXOncologyUSA

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

05-01-2015

Antibiotic specialist Cempra has announced positive top-line results from its pivotal Phase III trial…

Antibiotics and Infectious diseasesBiotechnologyCempraResearchsolithromycinUSA

US FDA approves wider use for Vertex’ Kalydeco

US FDA approves wider use for Vertex’ Kalydeco

30-12-2014

US biotech firm Vertex Pharmaceuticals says the US Food and Drug Administration has approved a supplemental…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

US health care predictions from Steven Burrill

US health care predictions from Steven Burrill

24-12-2014

US politics will continue to be characterized by partisanship as the Republican majorities in the House…

BiosimilarsBiotechnologyHealthcarePoliticsRegulationUSA

NewLink Genetic and Merck Ebola collaboration gets $30 million government award

23-12-2014

US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

1 to 25 of 285 results

Back to top